A Central Coast woman shares her transformative journey on GLP-1 drugs, losing three dress sizes and halting debilitating migraines, as experts call for exercise mandates and PBS access expands.
Western Australian medicinal cannabis producer Cannaponics plans a 2026 ASX listing, aiming to capitalise on the booming global legal market. Discover their unique strategy.
A Townsville family's desperate fight for a lifesaving cancer drug is stalled by PBS bureaucracy. Their plea highlights systemic delays affecting patients across Australia. Read their story.
Millions of Australians will save on prescription costs as PBS co-payments drop to $31.60 from New Year's Day. Find out how the federal government's policy affects you.
ASX-bound Equus Energy plans to find partners for its offshore WA gas project by mid-2026, aiming to fill the gap as North West Shelf production declines. Read more.
A Kambah mother fights for PBS reform so her sons with Crohn's can access biologics, a first-line treatment in other OECD nations, instead of 18 tablets daily. #Health #Crohns #Australia
Mayne Pharma's stock plummeted 20% after the government removed key products from the PBS. Discover the full impact on investors and the pharmaceutical sector.
Fremantle's iconic 1898 Trade Hall building hits the market with a $7 million price tag. This heritage-rich property offers commercial and residential potential in the heart of the port city.
Leading Australian cancer specialists reveal systemic failures in treatment access and demand urgent government action to save lives.
A rare piece of Canberra's history is up for grabs as the 19th-century Ginninderra Schoolhouse and entire village hit the market. Explore this unique investment opportunity in the capital.